Related Experiment Video
Updated: Jul 10, 2026
10:32
Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing
Published on: January 11, 2013
Intraoperative hyperglycemia and cognitive decline after CABG
Ferenc Puskas1, Hilary P Grocott, William D White
1Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina 27710, USA.
The Annals of Thoracic Surgery
|October 24, 2007
Summary
Intraoperative hyperglycemia, or high blood sugar during surgery, is linked to neurocognitive dysfunction (NCD) in patients without diabetes undergoing coronary artery bypass grafting (CABG). This finding highlights a specific risk factor for cognitive impairment after heart surgery.
Area of Science:
- Cardiology
- Neurology
- Metabolic Disorders
Background:
- Neurocognitive dysfunction (NCD) is a recognized complication following cardiac procedures.
- The specific factors contributing to NCD post-cardiac surgery remain incompletely understood.
- Hyperglycemia is a known factor that can worsen cerebral injury, prompting investigation into its role in post-operative NCD.
Purpose of the Study:
- To investigate the association between intraoperative hyperglycemia and the development of neurocognitive dysfunction (NCD) after cardiac operations.
- To determine if hyperglycemia exacerbates NCD in patients undergoing coronary artery bypass graft (CABG) surgery.
Main Methods:
- A cohort of 525 patients undergoing on-pump CABG procedures were assessed.
- Cognitive function was evaluated at baseline and six weeks post-surgery.
- Multivariable linear regression analysis was employed to examine the relationship between intraoperative hyperglycemia (glucose ≥ 200 mg/dL) and NCD, with separate analyses for diabetic and non-diabetic patients.
Main Results:
- In non-diabetic patients, intraoperative hyperglycemia was significantly associated with a decline in cognitive function at six weeks, even after adjusting for covariates (p = 0.0351).
- In contrast, hyperglycemia did not demonstrate a significant effect on cognitive function in diabetic patients.
- These results indicate a differential impact of hyperglycemia on neurocognitive outcomes based on diabetic status.
Conclusions:
- Intraoperative hyperglycemia is identified as a risk factor for neurocognitive dysfunction (NCD) in non-diabetic patients undergoing coronary artery bypass graft (CABG) surgery.
- The findings suggest that managing blood glucose levels during cardiac procedures may be crucial for preventing cognitive decline in this patient population.
Related Concept Videos
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:21Hyperosmolar Hyperglycemic State
Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...